Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder
Conditions: Anhedonia Interventions: Drug: Toludesvenlafaxine hydrochloride sustained-release tablets; Drug: Desvenlafaxine succinate sustained-release tablets Sponsors: Jiangsu Province Nanjing Brain Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Condition:   Hot Flashes Interventions:   Drug: Fezolinetant;   Drug: Paroxetine;   Drug: Citalopram;   Drug: Escitalopram;   Drug: Desvenlafaxine;   Drug: Venlafaxine;   Drug: Gabapentin;   Drug: Clonidine;   Drug: Pregabalin;   Drug: Oxybutynin;   Drug: Any other SSRI/SNRI not already specified;   Drug: Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above Sponsor:   Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Conditions: Hot Flashes Interventions: Drug: Fezolinetant; Drug: Paroxetine; Drug: Citalopram; Drug: Escitalopram; Drug: Desvenlafaxine; Drug: Venlafaxine; Drug: Gabapentin; Drug: Clonidine; Drug: Pregabalin; Drug: Oxybutynin; Drug: Any other SSRI/SNRI not already specified; Drug: Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above Sponsors: Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Predictors of Cognitive Outcomes in Geriatric Depression
Conditions:   Major Depressive Disorder;   Neuroticism;   Cognitive Change;   Stress Intervention:   Drug: Sertraline, bupropion, desvenlafaxine Sponsors:   David Steffens;   National Institute of Mental Health (NIMH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2022 Category: Research Source Type: clinical trials